Singh, J. 2024. Ceftobiprole medocaril (Zevtera) – FDA approved antibiotic for three infections including methicillin-resistant Staphylococcus aureus. Journal of Molecular Chemistry. 4, 2 (Apr. 2024), 692. DOI:https://doi.org/10.62110/sciencein.jmc.2024.692.